Published in Haematologica on December 01, 2006
Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics. Am J Physiol Cell Physiol (2013) 1.56
Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia. Blood (2011) 1.25
Pharmacotherapy in sickle cell disease--state of the art and future prospects. Br J Haematol (2009) 0.92
Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease. Exp Biol Med (Maywood) (2016) 0.88
Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters. Exp Hematol (2011) 0.87
Formulations for children: problems and solutions. Br J Clin Pharmacol (2015) 0.87
Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen. Orphanet J Rare Dis (2011) 0.85
Re-evaluation of cytostatic therapies for meningiomas in vitro. J Cancer Res Clin Oncol (2014) 0.79
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. J Clin Pharmacol (2015) 0.76
A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med (2011) 7.21
The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol (2013) 4.05
Downward trends in the prevalence of childhood overweight in the setting of 12-year school- and community-based programmes. Public Health Nutr (2008) 3.53
Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One (2011) 2.84
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology (2002) 2.56
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology (2005) 2.33
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology (2012) 2.01
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology (2007) 1.94
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl (2006) 1.86
Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study. Dis Colon Rectum (2011) 1.82
Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood (2002) 1.82
Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion (2009) 1.78
Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis. Am J Respir Crit Care Med (2010) 1.71
Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Haematologica (2008) 1.71
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program. Blood (2011) 1.71
Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood (2010) 1.69
Type II endoleaks after endovascular repair of abdominal aortic aneurysm are not always a benign condition. J Vasc Surg (2013) 1.68
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58
Relationship between ventilatory settings and barotrauma in the acute respiratory distress syndrome. Intensive Care Med (2002) 1.57
Revision total hip arthroplasty performed after fracture of a ceramic femoral head. A multicenter survivorship study. J Bone Joint Surg Am (2003) 1.52
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily. J Hepatol (2007) 1.49
Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47
Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma. Liver Int (2009) 1.40
Decrease in lung nitric oxide production after peritonitis in mice with sickle cell disease. Crit Care Med (2007) 1.39
Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion (2009) 1.29
Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med (2008) 1.28
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl (2005) 1.28
CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog (2011) 1.26
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol (2006) 1.25
Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS Microbiol Lett (2005) 1.20
Association of caffeine intake and histological features of chronic hepatitis C. J Hepatol (2011) 1.17
Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children. Antimicrob Agents Chemother (2004) 1.16
Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion (2006) 1.14
Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood (2002) 1.12
Patterns of mortality in sickle cell disease in adults in France and England. Hematol J (2002) 1.12
Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France. J Med Virol (2010) 1.11
Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant (2005) 1.11
Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection. PLoS Pathog (2013) 1.10
The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med (2003) 1.09
CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation. Sci Transl Med (2010) 1.08
Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team. J Antimicrob Chemother (2006) 1.07
Estimation of the difference in HbF expression due to loss of the 5' δ-globin BCL11A binding region. Haematologica (2012) 1.06
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study. Br J Haematol (2014) 1.05
Unexpected high frequency of P46L TNFRSF1A allele in sub-Saharan West African populations. Eur J Hum Genet (2005) 1.04
Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation. Blood (2010) 1.04
Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica (2012) 1.03
Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes. Am J Respir Crit Care Med (2005) 1.03
Computer-assisted analysis helps detect inner dynein arm abnormalities. Am J Respir Crit Care Med (2002) 1.02
Predicting the costs of allogeneic sibling stem-cell transplantation: results from a prospective, multicenter, French study. Transplantation (2004) 1.00
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia. Haematologica (2013) 1.00
Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine (Baltimore) (2009) 0.99
Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice. Respir Res (2007) 0.99
N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Circulation (2004) 0.98
Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens (2013) 0.98
Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study. J Clin Microbiol (2006) 0.98
Cardiac autonomic control during balloon carotid angioplasty and stenting. Can J Physiol Pharmacol (2003) 0.97
Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol (2007) 0.97
Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis. J Clin Endocrinol Metab (2007) 0.97
Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease. Haematologica (2010) 0.96
Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities. PLoS One (2009) 0.96
Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol (2010) 0.95
Complications and treatment of patients with β-thalassemia in France: results of the National Registry. Haematologica (2009) 0.95
Long-term effects of an educational seminar on antibiotic prescribing by GPs: a randomised controlled trial. Br J Gen Pract (2013) 0.94
A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood (2009) 0.93
Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis. J Clin Endocrinol Metab (2006) 0.91
Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma. Dig Liver Dis (2012) 0.91
Factors associated with dyspnea in adult patients with sickle cell disease. Chest (2005) 0.91
Slow-release melarsoprol microparticles. Int J Pharm (2002) 0.90
Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci (2003) 0.89
[Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents]. C R Biol (2004) 0.89
Lactobacillus rhamnosus R11 consumed in a food supplement survived human digestive transit without modifying microbiota equilibrium as assessed by real-time polymerase chain reaction. J Mol Microbiol Biotechnol (2008) 0.89
MRI features of intrahepatic extramedullary haematopoiesis in sickle cell anaemia. Cancer Imaging (2006) 0.89
The impact of aortic endografts on renal function. J Vasc Surg (2005) 0.89
Two French Caucasian families with dominant thalassemia-like phenotypes due to hyper unstable hemoglobin variants: Hb Sainte Seve [codon 118 (-T)] and codon 127 [CAG-->TAG (Gln-->stop]). Hemoglobin (2005) 0.88
Clinical management of adult sickle-cell disease. Curr Opin Hematol (2012) 0.88
Anal carcinoma: incidence and effect of cumulative infections. AIDS (2004) 0.88
[Acute complications in sickle cell disease]. Rev Prat (2004) 0.88
Induced sputum versus bronchoalveolar lavage during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med (2003) 0.87
Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells. Blood (2006) 0.87
Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl Environ Microbiol (2006) 0.87
Origin of the prevalent SFTPB indel g.1549C > GAA (121ins2) mutation causing surfactant protein B (SP-B) deficiency. Am J Med Genet A (2006) 0.87
The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation (2007) 0.87
Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease. Medicine (Baltimore) (2011) 0.86
Past excessive alcohol consumption: a major determinant of severe liver disease among newly referred hepatitis C virus infected patients in hepatology reference centers, France, 2001. Ann Epidemiol (2005) 0.86
Expertise of French laboratories in detection, genotyping, and quantification of hepatitis C virus RNA in serum. J Clin Microbiol (2004) 0.86
Colon ischemia following abdominal aortic aneurysm repair in the era of endovascular abdominal aortic repair. J Vasc Surg (2008) 0.86